Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Molecular Cancer Therapeutics|May 20, 2016
Preclinical Evaluation of AMG 337, a Highly Selective Small Molecule MET Inhibitor, in Hepatocellular CarcinomaZhiqiang Du, Sean Caenepeel, Yuqing Shen, et al.
Clinical Therapeutics|July 18, 2016
Lanreotide Autogel in the Treatment of Idiopathic Refractory Diarrhea: Results of an Exploratory, Controlled, Before and After, Open-label, Multicenter, Prospective Clinical TrialRaf Bisschops, Vincent De Ruyter, Gauthier Demolin, et al.
Molecular Cancer Therapeutics|October 5, 2019
Dual Inhibition of Angiopoietin-TIE2 and MET Alters the Tumor Microenvironment and Prolongs Survival in a Metastatic Model of Renal Cell CarcinomaMay Elbanna, Ashley R Orillion, Nur P Damayanti, et al.
Gut|September 2, 2018
Population-level analysis of Blastocystis subtype prevalence and variation in the human gut microbiotaRaul Y Tito, Samuel Chaffron, Clara Caenepeel, et al.
Oncotarget|May 10, 2014
MDM2 antagonists synergize broadly and robustly with compounds targeting fundamental oncogenic signaling pathwaysAnne Y Saiki, Sean Caenepeel, Dongyin Yu, et al.
Neurogastroenterology and Motility|March 31, 2022
A double-blind randomized, multicenter, placebo-controlled study of itopride in functional dyspepsia postprandial distress syndromeFlorencia Carbone, Alain Vandenberghe, Lieselot Holvoet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 10, 2020
Effects of Rome IV Definitions of Functional Dyspepsia Subgroups in Secondary CareKaren Van den Houte, Florencia Carbone, Nick Goelen, et al.
Molecular Cancer Research : MCR|July 29, 2017
Selective MET Kinase Inhibition in MET-Dependent Glioma Models Alters Gene Expression and Induces Tumor PlasticityCorina N A M van den Heuvel, Anna C Navis, Tessa de Bitter, et al.
Gut|January 8, 2024
Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebo-controlled trialLisse Decraecker, Danny De Looze, David P Hirsch, et al.
Gastroenterology|February 24, 2024
Efficacy and Findings of a Blinded Randomized Reintroduction Phase for the Low FODMAP Diet in Irritable Bowel SyndromeKaren Van den Houte, Esther Colomier, Karen Routhiaux, et al.
Pageof 12